Coherus Oncology (CHRS) Net Income Attributable to Noncontrolling Interests (2014 - 2018)
Coherus Oncology's Income from Non-Controlling Interests was -$70,000 in FY2018, compared with -$116,000 in FY2017.
Powered by 
Analysis
Coherus Oncology (CHRS) Net Income Attributable to Noncontrolling Interests (2014 - 2018) Analysis & Trends
From FY2014 onward, Coherus Oncology has reported Income from Non-Controlling Interests for 5 years.
- The FY2018 figure marks the highest annual Income from Non-Controlling Interests since FY2014.
- Per Business Quant data, Income from Non-Controlling Interests in earlier years was -$116,000 in FY2017, -$451,000 in FY2016, -$678,000 in FY2015 and -$44,000 in FY2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | - |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Coherus Oncology | 119.30 Mn | -516.84 Mn | 10.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | -18,000.00 |
| Jun 30, 2018 | -47,000.00 |
| Mar 31, 2018 | -5,000.00 |
| Dec 31, 2017 | -2,000.00 |
| Sep 30, 2017 | -4,000.00 |
| Jun 30, 2017 | -66,000.00 |
| Mar 31, 2017 | -44,000.00 |
| Dec 31, 2016 | -23,000.00 |
| Sep 30, 2016 | -95,000.00 |
| Jun 30, 2016 | -183,000.00 |
| Mar 31, 2016 | -150,000.00 |
| Dec 31, 2015 | -189,000.00 |
| Sep 30, 2015 | -151,000.00 |
| Jun 30, 2015 | -224,000.00 |
| Mar 31, 2015 | -114,000.00 |
| Dec 31, 2014 | 111,000.00 |
| Sep 30, 2014 | -42,000.00 |
| Jun 30, 2014 | -113,000.00 |
API Access
Coherus Oncology Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();